Author: healthadmin

Survivors of childhood abuse often remain traumatized into adulthood, but those whose abuse was justified by religious teachings exhibit even higher levels of psychological distress. Recent research has found that these people report higher rates of anxiety, depression, stress, and anger in adulthood compared to those who have experienced secular forms of abuse. These findings were published in the journal Psychology of Religion and Spirituality. Faith and spirituality are generally considered protective factors in psychology. Religious communities regularly provide social support and a sense of common purpose, helping individuals recover from traumatic events. High religious involvement is consistently associated with…

Read More

Drinking fruit juices and sugary drinks regularly from childhood to adulthood may increase your chances of developing high blood pressure later in life, according to a new study published today in Circulation, the American Heart Association’s flagship journal. “Eating habits during childhood can have a lasting impact on health,” said lead study author Basanti Malik, Ph.D., MSc, associate professor and Canada Research Chair in Nutrition and Chronic Disease Prevention in the Department of Nutritional Sciences at the University of Toronto’s Temerty Faculty of Medicine and adjunct faculty member in the Department of Nutrition at the Harvard T. H. Chan School…

Read More

Artificial intelligence-powered health platform Prosper Medical has secured $16 million in seed funding to make concierge medicine more accessible through AI-powered platform expansion. FUSE led the funding round for Prosper Medical, with participation from Aurum Partners, Better.vc, Cal Innovation Fund, Fluent, Latitude Capital, Knoll Ventures, and Western Technology Investment. The startup was founded by Ryan McQuaid and Dr. James Wantuck. He previously built PlushCare, one of the country’s first direct-to-consumer telemedicine platforms. PlushCare was acquired by Accolade in 2021 in a deal valued at $450 million. “We’ve grown PlushCare to more than 1 million patient visits a year, and through…

Read More

Clinician-driven artificial intelligence platform Anterior and health tech company Stellarus on Thursday entered into a strategic partnership to automate prior authorizations. The partnership aims to support providers by automating tasks such as case investigation and policy enforcement, allowing teams to focus on complex decisions. The companies say providers will receive initial approval faster, ultimately providing members with faster access to care. Through this partnership, Anterior’s clinical AI will be integrated with Stellarus’ AtlasIQ platform to help health plans quickly deploy prior authorizations. All final decisions will be made by licensed clinicians, not AI tools, executives say. “Every plan wants to…

Read More

Antimicrobial resistance is one of the world’s most worrying public health challenges. Multidrug-resistant (MDR) Gram-negative bacteria are increasingly rendering even last-line antibiotics ineffective, significantly increasing mortality rates. Polymyxins are a type of antibiotic and one of the few treatment options available for serious infections caused by resistant bacteria. Escherichia coli. However, its widespread use is limited by severe side effects such as renal and neurotoxicity. Capitalizing on this gap, researchers have now developed an innovative strategy where bacteria are more susceptible to these antibiotics, allowing doctors to use lower doses safely without sacrificing efficacy. This innovative approach shifts the focus…

Read More

Get your daily dose of health and medicine every weekday with Morning Rounds, STAT’s free newsletter. Sign up here. good morning. This week is almost over. But first, it must pass the FDA’s peptide review board for two days. Scroll down to see a preview. More than 1,000 people die from Ebola hemorrhagic fever More than 1,000 people have been confirmed dead in the fastest-growing Ebola outbreak in history, according to the Africa CDC. “These people are dying. They’re dying because there’s no vaccine, there’s no medicine, there’s no funding,” Health Agency Director General Jean Caseya said yesterday. Read more…

Read More

Kevin Carter, via Getty Get your news from sources that are not owned and controlled by oligarchies. Sign up for free mother jones daily. This story was first publishedy of guardian Reprinted here as part of. climate desk collaboration. in the middle of summer Despite President Donald Trump’s efforts to dismiss global warming as a “con man” and a “hoax,” a new poll finds that a majority of Americans associate increasingly severe weather with the climate crisis, with dangerous heat, droughts and flooding. Grace Adcox, senior climate strategist at Data for Progress, said this was a sign that attempts to…

Read More

A new mouse study led by UCLA Health suggests that inflammation during pregnancy can cause autism-like changes in offspring, but also suggests that these brain and behavioral effects can be rapidly but temporarily reversed in adulthood by short-term administration of the immunosuppressant rapamycin. Even mild inflammation during the third trimester has been shown to cause autism-like symptoms in offspring, abnormal brain growth, seizures, and hypersensitivity to everyday sensory input that persists into adulthood. In a study published in a journal nature communicationsUCLA researchers found that a single dose of the drug rapamycin significantly improved brain signaling and behavioral symptoms in…

Read More

Primary biliary cholangitis is a rare autoimmune disease that affects the liver and can progress to cirrhosis. It occurs when the immune system attacks the small bile ducts in the liver. As a result, bile builds up, causing inflammation and progressive liver damage. Although first-line treatments exist, new treatment options must be developed because 40% of patients do not respond adequately to or cannot tolerate them. Research published in journals Trends in molecular medicine reveals that peroxisome proliferator-activated receptors (PPARs) have emerged as potential therapeutic targets. The study was led by Professor Manuel Vázquez Carrera of UB’s School of Pharmacy…

Read More